These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34967942)

  • 1. Economic evaluation of deep brain stimulation compared with vagus nerve stimulation and usual care for patients with refractory epilepsy: A lifetime decision analytic model.
    Chan HY; Wijnen BFM; Majoie MHJM; Evers SMAA; Hiligsmann M
    Epilepsia; 2022 Mar; 63(3):641-651. PubMed ID: 34967942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy.
    de Kinderen RJ; Postulart D; Aldenkamp AP; Evers SM; Lambrechts DA; Louw AJ; Majoie MH; Grutters JP
    Epilepsy Res; 2015 Feb; 110():119-31. PubMed ID: 25616464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation
    Vincent T; Li Q; Zhang L; Stokes M; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    J Med Econ; 2022; 25(1):1218-1230. PubMed ID: 36384429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Anterior Thalamic Deep Brain Stimulation as an Alternative Therapy in Patients with Previously Failed Vagus Nerve Stimulation for Refractory Epilepsy.
    Park HR; Choi SJ; Joo EY; Seo DW; Hong SB; Lee JI; Hong SC; Lee S; Shon YM
    Stereotact Funct Neurosurg; 2019; 97(3):176-182. PubMed ID: 31533117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy.
    Wijnen BFM; de Kinderen RJA; Lambrechts DAJE; Postulart D; Aldenkamp AP; Majoie MHJM; Evers SMAA
    Epilepsy Res; 2017 May; 132():91-99. PubMed ID: 28364726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior Nucleus of the Thalamus Deep Brain Stimulation with Concomitant Vagus Nerve Stimulation for Drug-Resistant Epilepsy.
    Parisi V; Lundstrom BN; Kerezoudis P; Alcala Zermeno JL; Worrell GA; Van Gompel JJ
    Neurosurgery; 2021 Sep; 89(4):686-694. PubMed ID: 34333659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
    Chambers A; Bowen JM
    Ont Health Technol Assess Ser; 2013; 13(18):1-37. PubMed ID: 24228081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States.
    Pietzsch JB; Garner AM; Marks WJ
    Neuromodulation; 2016 Oct; 19(7):689-697. PubMed ID: 27491661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and expected gain in lifetime health from intensive care versus general ward care of 30,712 individual patients: a distribution-weighted cost-effectiveness analysis.
    Lindemark F; Haaland ØA; Kvåle R; Flaatten H; Norheim OF; Johansson KA
    Crit Care; 2017 Aug; 21(1):220. PubMed ID: 28830479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Analysis of Deep Brain Stimulation for Parkinson Disease in Taiwan.
    Fann JC; Chang KC; Yen AM; Chen SL; Chiu SY; Chen HH; Liou HH
    World Neurosurg; 2020 Jun; 138():e459-e468. PubMed ID: 32147563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarities between the responses to ANT-DBS and prior VNS in refractory epilepsy.
    Kulju T; Haapasalo J; Lehtimäki K; Rainesalo S; Peltola J
    Brain Behav; 2018 Jun; 8(6):e00983. PubMed ID: 29740975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: An interim analysis.
    de Kinderen RJ; Lambrechts DA; Wijnen BF; Postulart D; Aldenkamp AP; Majoie MH; Evers SM
    Epilepsia; 2016 Jan; 57(1):41-50. PubMed ID: 26617284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis.
    Fundament T; Eldridge PR; Green AL; Whone AL; Taylor RS; Williams AC; Schuepbach WM
    PLoS One; 2016; 11(7):e0159340. PubMed ID: 27441637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital costs associated with vagus nerve stimulation and medical treatment in pediatric patients with refractory epilepsy.
    Zhang L; Hall M; Lam SK
    Epilepsia; 2022 May; 63(5):1141-1151. PubMed ID: 35188675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.